The soft tissue malignancies include myxoid liposarcoma, 157 myxoid malignant fibrous histiocytoma 158 and its allied lesions, low-grade fibromyxoid sarcoma 159, 160 and low-grade myofibroblastic sarcoma, 161 myxoid chondrosarcoma, 158, 162 myxoid peripheral nerve sheath tumors, 139 myxoid rhabdomyosarcoma, 163 malignant myoepithelioma, 164 myxoid synovial sarcoma, 165 myxoid follicular dendritic cell sarcoma, 166 myxoid dermatofibrosarcoma protuberans, 167 metastatic chordoma, and its benign mimic, parachordoma
Wegovy European Medicines Agency medicine overview
They support appetite control, help lower blood sugar, and are associated with sustained weight loss when used alongside healthy habits
This information can support a more personalized conversation about whether GLP-1 agonist therapy, dual-receptor compounds, or alternative approaches align with your metabolic needs